PMDA — authorised 25 September 2020
- Marketing authorisation holder: TAKEDA PHARMACEUTICAL COMPANY LIMITED
- Status: approved
🇯🇵 Zejula in Japan
PMDA authorised Zejula on 25 September 2020
Marketing authorisation
Zejula in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in Japan
Frequently asked questions
Is Zejula approved in Japan?
Yes. PMDA authorised it on 25 September 2020.
Who is the marketing authorisation holder for Zejula in Japan?
TAKEDA PHARMACEUTICAL COMPANY LIMITED holds the Japanese marketing authorisation.